ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 759,54
-0,48%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. OncoCyte Corporation (OCX)

  7. OncoCyte Corporation (OCX) Actualités

OCX

OncoCyte (OCX)

OncoCyte Corporation
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:OCX
DateHeureSourceTitreSymboleSociété
13/06/202322h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:OCXOncoCyte Corporation
09/06/202312h02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:OCXOncoCyte Corporation
19/05/202322h52Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:OCXOncoCyte Corporation
01/05/202322h49Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:OCXOncoCyte Corporation
19/04/202300h50Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:OCXOncoCyte Corporation
14/04/202322h32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:OCXOncoCyte Corporation
12/04/202322h55Edgar (US Regulatory)Annual Report (10-k)AMEX:OCXOncoCyte Corporation
07/04/202316h39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:OCXOncoCyte Corporation
03/04/202312h02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:OCXOncoCyte Corporation
14/02/202317h34Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:OCXOncoCyte Corporation
10/11/202222h50Edgar (US Regulatory)Quarterly Report (10-q)AMEX:OCXOncoCyte Corporation
22/09/202223h39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:OCXOncoCyte Corporation
26/05/202222h15Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:OCXOncoCyte Corporation
18/04/202215h15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:OCXOncoCyte Corporation
29/07/202122h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:OCXOncoCyte Corporation
07/07/202122h06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:OCXOncoCyte Corporation
15/06/202114h03Business WireEchelonDx & Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test Offeri...AMEX:OCXOncoCyte Corporation
09/06/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:OCXOncoCyte Corporation
01/06/202122h26Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:OCXOncoCyte Corporation
28/05/202123h07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:OCXOncoCyte Corporation
21/05/202122h11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:OCXOncoCyte Corporation
08/03/202122h17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:OCXOncoCyte Corporation
05/03/202119h44Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:OCXOncoCyte Corporation
05/03/202114h01Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...AMEX:OCXOncoCyte Corporation
01/03/202122h34Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:OCXOncoCyte Corporation
05/02/202112h07Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)AMEX:OCXOncoCyte Corporation
18/05/202012h07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:OCXOncoCyte Corporation
18/03/202020h15Edgar (US Regulatory)Unknown (sec Staff)AMEX:OCXOncoCyte Corporation
14/02/201914h00GlobeNewswire Inc.BioTime Provides Business Update Including Information on AgeX, OncoCyte and AsteriasAMEX:OCXOncoCyte Corporation
14/08/201822h10GlobeNewswire Inc.OncoCyte Reports Second Quarter 2018 Financial Results and Positive Corporate DevelopmentsAMEX:OCXOncoCyte Corporation
 Showing the most relevant articles for your search:AMEX:OCX

Dernières Valeurs Consultées

COIN
SHINTAMAUST
Shintama
NASDAQ
ISRLW
Israel Acquisitions
KOSPI
610035
Leverage Representative ...
EU
I301T
I301T
BIT
UC921V
Unicredit Bank
NASDAQ
NVTL
UNSW
MOONCETH
BITMOT
814004
Caixabank Tf 1,125% Mg24...
BIT
UC4WVJ
Unicredit Bank
NASDAQ
SWIN.NV
BOV
PETRE385
PETRE385 Ex:35,62
BIT
P21K31
NLBNPIT21K31 20240620 38...
USOTC
EXCOF
Exco Technologies (PK)
BOV
ABEVT217
ABEVT217 Ex:21,73
COIN
HITTGBP
HitchainCoin
EU
I309T
I309T
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés